AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΊπŸ‡¬

BEVACIZUMAB in Uganda

6 products registered with NDA β€” 6 active

Brand / ProductReg. No.HolderStatusExpires
BEVACIZUMAB
PARENTERAL ORDINARY VIALS
UNKNOWN-b8b848d5F. HOFFMANN LA- ROCHEactiveβ€”
BEVACIZUMAB
PARENTERAL ORDINARY VIALS
UNKNOWN-81470da6HETERO BIOPHARMA LIMITED,activeβ€”
BEVACIZUMAB
PARENTERAL ORDINARY INFUSION DRY VIALS/BOTTLES
UNKNOWN-df649eb6JSC BIOCAD, SAINT PETERSBURGactiveβ€”
BEVACIZUMAB
PARENTERAL ORDINARY VIALS
UNKNOWN-19694574F. HOFFMANN LA- ROCHEactiveβ€”
BEVACIZUMAB
PARENTERAL ORDINARY VIALS
UNKNOWN-397ddfe5HETERO BIOPHARMA LIMITED,activeβ€”
BEVACIZUMAB
PARENTERAL ORDINARY INFUSION DRY VIALS/BOTTLES
UNKNOWN-f5bc1c92JSC BIOCAD, SAINT PETERSBURGactiveβ€”

BEVACIZUMAB β€” NDA Registration Details

NDA (Uganda) has 6 registered products containing BEVACIZUMAB, of which 6 are currently active. Data is sourced directly from the official NDA drug register and refreshed daily.

Track BEVACIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Bevacizumab β€” Uganda (NDA) | AfricaRegulatory